7000 ORAL Final Overall Survival (OS) Analysis of COU-AA-301, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pretreated With Docetaxel
2011 ◽
Vol 47
◽
pp. S483-S484
◽
2012 ◽
Vol 13
(10)
◽
pp. 983-992
◽
2015 ◽
Vol 16
(2)
◽
pp. 152-160
◽
2016 ◽
Vol 19
(8)
◽
pp. 777-784
◽
2015 ◽
Vol 21
(14)
◽
pp. 3170-3177
◽